OSTX End Period Cash Flow from 2010 to 2024

OSTX Stock   3.02  1.44  32.29%   
OS Therapies End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, OS Therapies End Period Cash Flow regression line of annual values had r-squared of  0.01 and arithmetic mean of  83,839. View All Fundamentals
 
End Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
39 K
Current Value
77.7 K
Quarterly Volatility
26.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of OS Therapies Incorporated over the last few years. It is OS Therapies' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Pretty Stable
   End Period Cash Flow   
       Timeline  

OSTX End Period Cash Flow Regression Statistics

Arithmetic Mean83,839
Geometric Mean80,705
Coefficient Of Variation31.63
Mean Deviation11,685
Median80,788
Standard Deviation26,515
Sample Variance703.1M
Range132.5K
R-Value0.11
Mean Square Error748.2M
R-Squared0.01
Significance0.70
Slope645.62
Total Sum of Squares9.8B

OSTX End Period Cash Flow History

202477.7 K
202339 K
2022171.5 K

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow39 K77.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.